Sanda Membrane (688101.SH): Affiliated company Shandong Tianli Pharmaceutical was affected by peripheral markets in the first half of the year, and revenue and profit declined to a certain extent

Gelonghui Finance · Oct 10, 2023 10:22

Gelonghui October 10?688101.SH said in its 2023 semi-annual performance statement that the company's associate, Shandong Tianli Pharmaceutical Co., Ltd. was affected by the external market in the first half of the year, resulting in a decline in revenue and profit to a certain extent, resulting in the company's recognized investment income lower than the same period last year, resulting in a lower growth rate of net profit than the growth rate of receivables.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

三达膜(688101.SH)：联营公司山东天力药业上半年受外围市场影响，收入、利润有一定程度的下滑

Sanda Membrane (688101.SH): Affiliated company Shandong Tianli Pharmaceutical was affected by peripheral markets in the first half of the year, and revenue and profit declined to a certain extent

Risk Disclaimer

Statement